Northwest Biothrputcs Inc
(NWBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -249,522 | -55,426 | 2,626 | -20,812 | -27,357 |
| Depreciation Amortization | 2,273 | 1,089 | 437 | 1,451 | 1,036 |
| Accounts payable and accrued liabilities | 986 | N/A | 1,208 | N/A | N/A |
| Other Working Capital | 2,352 | 2,440 | 1,246 | -4,111 | -4,426 |
| Other Operating Activity | 222,021 | 38,029 | -13,056 | -8,387 | 4,866 |
| Operating Cash Flow | $-21,890 | $-13,868 | $-7,539 | $-31,859 | $-25,881 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,548 | -1,306 | -62 | -360 | -246 |
| Net Acquisitions | -1,560 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-5,108 | $-1,306 | $-62 | $-360 | $-246 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,062 | 6,061 | 1,240 | 7,000 | 6,500 |
| Debt Repayment | -153 | -1,427 | -64 | -749 | -749 |
| Common Stock Issued | 26,523 | 15,564 | 5,671 | 9,101 | 4,460 |
| Other Financing Activity | -1,556 | 0 | 178 | -5,400 | -5,393 |
| Financing Cash Flow | $36,876 | $20,198 | $7,025 | $9,952 | $4,818 |
| Exchange Rate Effect | -1,000 | 559 | 968 | 415 | 1,055 |
| Beginning Cash Position | 372 | 372 | 372 | 22,224 | 22,224 |
| End Cash Position | 9,250 | 5,955 | 764 | 372 | 1,970 |
| Net Cash Flow | $8,878 | $5,583 | $392 | $-21,852 | $-20,254 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,890 | -13,868 | -7,539 | -31,859 | -25,881 |
| Capital Expenditure | -3,548 | -1,306 | -62 | -360 | -246 |
| Free Cash Flow | -25,438 | -15,174 | -7,601 | -32,219 | -26,127 |